Loading organizations...
§ Private Profile · Daejeon, Taejon-jikhalsi, South Korea
Biotech company developing cell-penetrating therapeutic antibodies.
Orum Therapeutics has raised $220.8M across 4 funding rounds.
Orum Therapeutics has raised $220.8M in total across 4 funding rounds.
Orum Therapeutics has raised $220.8M in total across 4 funding rounds.
Orum Therapeutics's investors include IMM Investment, Atinum Investment, InterVest, KB Investment, KDB, KTB Network, Smilegate Investment, Stassets Investment, Yeo Jung Moon, M.D., Ph.D., LB Investment.
Orum Therapeutics has raised $220.8M across 4 funding rounds. Most recently, it raised $98.8M Other Equity in December 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Dec 1, 2025 | $98.8M Venture Round | — | — | Announced |
| Jun 23, 2021 | $84M Series B | IMM Investment | Atinum Investment, Intervest, KB Investment, KDB | Announced |
| Jul 17, 2019 | $30M Series B | — | IMM Investment, Intervest, KB Investment, KTB Network, Smilegate Investment, Stassets Investment | Announced |
| Jun 14, 2017 | $8M Series A | — | YEO Jung Moon, M.d., Ph.d., KB Investment, LB Investment | Announced |